April 29, 2025

New Oral Option Approved for GCA

The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 18, 2025

Weekly Semaglutide Boosts PAD Function: Study

Semaglutide significantly increased walking distance and improved symptoms and quality of life in patients with peripheral artery disease and type 2 diabetes over 52 weeks.

Conexiant

April 17, 2025

Accuracy of AI-Based Retinal Photographic CVD Risk Assessment

Predictive accuracy of the tool was comparable to the traditional WHO assessment for 10-year CVD events.

Conexiant

April 16, 2025

Is Primary Care Becoming Pay-to-Play?

“It’s a way to practice self-preservation in this field that is punishing patients and doctors alike” — one internist explains why some rural physicians are opting for concierge care despite the access trade-offs.

KFF Health News

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 15, 2025

Tenecteplase Matches Alteplase in Stroke Outcomes

In a registry-based study of 79,550 patients, tenecteplase showed comparable short-term safety and effectiveness to alteplase for acute ischemic stroke, with no significant differences in functional outcomes or hemorrhagic events.

Conexiant

April 14, 2025

1 in 5 Patients Face Stroke Within Decade After TIA

Meta-analysis of 171,000+ patients shows persistent long-term stroke risk following TIA, with half of recurrent events occurring after the first year.

Conexiant

April 11, 2025

Combination Lipid Therapy Lowers CV Risk

Meta-analysis shows a 19% reduction in all-cause mortality with combination lipid-lowering therapy vs statin monotherapy in high-risk patients.

Conexiant